IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Industrial Biotech

Evonik, OPX to develop biobased routes to specialty chemicals

1:34 PM MDT | May 14, 2013 | Rebecca Coons

Evonik Industries and Boulder, CO–based industrial biotechnology firm OPX Biotechnologies say they have entered into a joint development agreement to find biobased routes to undisclosed specialty chemicals. Under the terms of the agreement, OPX will use its Efficiency Directed Genome Engineering (EDGE) technology to develop bioprocesses. "There's a growing market demand for more sustainable products and processes, and [OPX] is an excellent partner to help us meet that demand because their technology can create high-value, biobased chemicals quickly and...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa